Introduction to Health Economics

Introduction to Health Economics: Key Terms and Vocabulary

Introduction to Health Economics

Introduction to Health Economics: Key Terms and Vocabulary

Health economics is a multidisciplinary field that applies economic theories and concepts to health and healthcare. To better understand this subject, it is essential to become familiar with some key terms and vocabulary. In this explanation, we will cover some of the most important terms and provide examples and practical applications to help illustrate their meaning.

1. Opportunity Cost

Opportunity cost is a fundamental concept in economics that refers to the value of the next best alternative that must be given up when making a decision. In healthcare, opportunity cost may refer to the value of the next best alternative use of resources, such as the value of forgone treatments or research when resources are used for a different purpose. For example, the opportunity cost of investing in a new cancer treatment may be the forgone investments in other healthcare areas, such as mental health or infectious diseases.

2. Supply and Demand

Supply and demand are two fundamental concepts in economics that explain how markets work. In healthcare, supply refers to the availability of healthcare resources, such as doctors, nurses, hospitals, and medical equipment. Demand refers to the need or desire for healthcare services, which is influenced by factors such as population size, income, and preferences. The interaction between supply and demand determines the price and quantity of healthcare services provided. For example, if the demand for a particular medical service increases, the price and quantity of the service will also increase, assuming the supply remains constant.

3. Marginal Analysis

Marginal analysis is a decision-making tool that involves comparing the additional benefits and costs of an action. In healthcare, marginal analysis is used to determine the optimal level of healthcare services, such as the number of hospital beds or the amount of funding for medical research. For example, a hospital administrator may use marginal analysis to determine the optimal number of beds by comparing the additional revenue generated by each bed to the additional cost of providing the bed.

4. Externalities

Externalities are costs or benefits that are not reflected in the market price of a good or service. In healthcare, externalities may arise when the consumption or production of healthcare services affects third parties who are not directly involved in the transaction. For example, the consumption of cigarettes imposes external costs on society in the form of increased healthcare costs and lost productivity due to smoking-related illnesses. Similarly, vaccination programs may impose external benefits on society by reducing the spread of infectious diseases.

5. Efficiency

Efficiency refers to the optimal use of resources to achieve a given objective. In healthcare, efficiency may refer to the optimal use of resources to provide healthcare services or to improve health outcomes. There are two types of efficiency: allocative efficiency and technical efficiency. Allocative efficiency refers to the optimal allocation of resources across different healthcare services or interventions. Technical efficiency refers to the optimal use of resources to provide a given healthcare service or intervention. For example, a healthcare system may be technically efficient if it provides high-quality care at a low cost, but it may not be allocatively efficient if it allocates resources to low-value services or interventions.

6. Health Technology Assessment (HTA)

Health technology assessment (HTA) is a multidisciplinary approach to evaluating the medical, economic, social, and ethical implications of healthcare technologies, such as drugs, devices, and procedures. HTA is used to inform decision-making about the adoption and use of healthcare technologies by healthcare systems and payers. HTA typically involves a systematic review of the scientific evidence, economic modeling, and stakeholder engagement. For example, an HTA of a new cancer drug may involve a review of the clinical trial data, a cost-effectiveness analysis, and consultations with clinicians, patients, and payers.

7. Cost-Effectiveness Analysis (CEA)

Cost-effectiveness analysis (CEA) is a type of economic evaluation that compares the costs and outcomes of two or more healthcare interventions. CEA is used to inform decision-making about the adoption and use of healthcare technologies by healthcare systems and payers. CEA typically involves the calculation of an incremental cost-effectiveness ratio (ICER), which represents the additional cost of a healthcare intervention per additional unit of outcome. For example, an CEA of a new cancer drug may involve the calculation of the ICER by comparing the additional cost of the drug to the additional years of life gained by patients.

8. Quality-Adjusted Life Year (QALY)

The quality-adjusted life year (QALY) is a measure of health outcomes that combines both the quantity and quality of life. QALYs are used in health economics to evaluate the effectiveness and value of healthcare interventions. One QALY is equivalent to one year of life in perfect health. QALYs are calculated by multiplying the

number of years of life gained by a healthcare intervention by a weighting factor that reflects the quality of life during those years. For example, a healthcare intervention that extends life by one year with perfect health would result in one QALY, while an intervention that extends life by one year with moderate health problems would result in less than one QALY.

9. Budget Impact Analysis (BIA)

Budget impact analysis (BIA) is an economic evaluation that assesses the financial impact of adopting a new healthcare technology or intervention on a healthcare system or payer. BIA is used to inform decision-making about the affordability and sustainability of healthcare technologies and interventions. BIA typically involves the estimation of the total cost of the new technology or intervention, taking into account the number of patients who will receive the intervention, the price of the intervention, and the duration of treatment. For example, a BIA of a new cancer drug may involve the estimation of the total cost of the drug over a five-year period, taking into account the number of patients who will receive the drug, the price of the drug, and the duration of treatment.

10. Health Econometric Modeling

Health econometric modeling is a statistical technique used to analyze the relationships between economic and health outcomes. Health econometric modeling is used to inform decision-making about healthcare policies and interventions. Health econometric modeling typically involves the use of regression analysis to estimate the causal effects of economic factors on health outcomes, taking into account potential confounding factors and biases. For example, a health econometric model may be used to estimate the effect of income on health outcomes, taking into account potential confounding factors such as age, education, and lifestyle factors.

Challenges and Future Directions

Health economics is a complex and multifaceted field that faces several challenges and future directions. One of the main challenges is the need to balance the goals of efficiency, equity, and quality in healthcare. While efficiency is important for ensuring the sustainability of healthcare systems, equity is essential for ensuring fair access to healthcare services and reducing health disparities. Quality is also critical for ensuring that healthcare services are effective and safe.

Another challenge is the need to address the rising costs of healthcare, which are driven by several factors, including an aging population, the increasing prevalence of chronic diseases, and the high cost of new healthcare technologies. Addressing these challenges will require innovative solutions, such as the use of alternative payment models, the promotion of prevention and wellness, and the integration of healthcare and social services.

In conclusion, health economics is a vital field that plays a critical role in informing decision-making about healthcare policies and interventions. To understand health economics, it is essential to become familiar with key terms and vocabulary, such as opportunity cost, supply and demand, marginal analysis, externalities, efficiency, health technology assessment, cost-effectiveness analysis, quality-adjusted life year, budget impact analysis, and health econometric modeling. By understanding these concepts, healthcare professionals, policymakers, and stakeholders can make informed decisions that promote the efficient, equitable, and high-quality provision of healthcare services.

Key takeaways

  • In this explanation, we will cover some of the most important terms and provide examples and practical applications to help illustrate their meaning.
  • In healthcare, opportunity cost may refer to the value of the next best alternative use of resources, such as the value of forgone treatments or research when resources are used for a different purpose.
  • For example, if the demand for a particular medical service increases, the price and quantity of the service will also increase, assuming the supply remains constant.
  • For example, a hospital administrator may use marginal analysis to determine the optimal number of beds by comparing the additional revenue generated by each bed to the additional cost of providing the bed.
  • For example, the consumption of cigarettes imposes external costs on society in the form of increased healthcare costs and lost productivity due to smoking-related illnesses.
  • For example, a healthcare system may be technically efficient if it provides high-quality care at a low cost, but it may not be allocatively efficient if it allocates resources to low-value services or interventions.
  • Health technology assessment (HTA) is a multidisciplinary approach to evaluating the medical, economic, social, and ethical implications of healthcare technologies, such as drugs, devices, and procedures.
May 2026 intake · open enrolment
from £90 GBP
Enrol